Although current clinical studies are insufficient to support those findings and the hypothesis that FGF23 is independently associated with bone mineralization decline in the elderly and CKD-MBD, several clinical studies show that FGF23 has been a potential predictor for fragility fractures. The gene discussed is FGF23; the disease is chronic kidney disease.